SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-13-030115
Filing Date
2013-05-23
Accepted
2013-05-23 15:26:27
Documents
1
Period of Report
2013-05-17

Document Format Files

Seq Description Document Type Size
1 rrd380973.html 3  
1 rrd380973.xml 3 4590
  Complete submission text file 0001181431-13-030115.txt   5967
Mailing Address 135 BEAVER ST WATHAM MA 02452
Business Address 135 BEAVER ST WATHAM MA 02452 1-781-398-0700
INTERLEUKIN GENETICS INC (Issuer) CIK: 0001037649 (see all company filings)

IRS No.: 943123681 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 1119 ST. PAUL STREET BALTIMORE MD 21202
Business Address
MOTT DAVID M (Reporting) CIK: 0001219871 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-32715 | Film No.: 13868151